Stark R., Henson R., Evans S.
Spinal metastases, a retrospective survey from a gen
eral hospital // Brain. — 1982. — V. 105. — P. 189.
Steeg P.
Biology of metastasis: mechanisms and targets of future therapies //
Program and abstracts of 22nd San Antonio Breast Cancer Symposium; December 8 11,
1999; San Antonio, Texas. (Mini symposium II: Micrometastases: biology, clinical rele
vance, and treatment.)
Stein R.C., Dowsett M., Cunningham D.C.,
è ñîàâò. Phase I/II study of the anti
oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer
Research Campaign Phase I/II Clinical Trials Committee Study // Br.J. Cancer. — 1990. —
V. 61. — P. 451 453.
Stewart A.F., Horst R.L., Deftos L.J., Cadman E.C., Lang R., Broadus A.E.
Biochemical evaluation of patients with cancer associated hypercalcaemia: evidence for
humoral and non humoral groups // N. Engl. J. Med. — 1980. — V. 303. — P. 1377 1383.
Stewart A.F., Vignery A., Silvergate A.
è ñîàâò. Quantitative bone histomorphometry
in humoral hypercalcaemia of malignancy: uncoupling of bone cell activity // J. Clin.
Endocrinol. Metab. — 1982. — V. 55 — P. 219 227.
Stewart A.F., Insogna K.L., Goltzman D., Broadus A.E.
Identification of adenylate
cyclase stimulating activity in extracts of tumor associated with humoral hypercalcaemia of
malignancy // Proc. Natl. Acad. Sci. USA. — 1983. — V. 80. — P. 1454 1459.
Stillman M., Foley K.
Breast cancer and epidural cord compression: diagnosis and
therapy // In: Breast diseases/ Ed. by J. Harris è ñîàâò. 2nd ed. Lippincott Company. —
1991. — P. 688 700.
Stoll B.A.
Does the malygnancy of breast cancer vary with age? // Clin. Oncol. —
1976. — V. 2.(1). — P. 73 80.
Stoll B.A.
Mechanism in endocrine therapy of bone metastases // J. R. Soc. Med. —
1985. — V. 78 (Suppl. 9). — P. 11 14.
Strewler G.J., Williams R.D., Nissenson R.A.
Human renal carcinoma cells produce
hypercalcaemia in the nude mouse and a novel protein recognised by parathyroid hormone
receptors // J. Clin. Invest. — 1983. — V. 71. — P. 769 774.
Strewler G.L., Stern P.H., Jacobs J.W.
è ñîàâò. Parathyroid hormone like protein
from renal carcinoma cells: structural and functional homology with parathyroid hormone
// J. Clin. Invest. — 1987. — V. 80. — P. 1803 1807.
Sulman C.
Le contence informatif des tests diagnostiques: application a la scintigra
phie et la radiographie osseuses chez des patientes presentant un cancer du sein //
G. Biophys et Med. Nucl. — 1984. — V. 2(3). — P. 94 96.
Suva L.J., Winslow G.A., Moseley J.M.
è ñîàâò. A parathyroid hormone related pro
tein implicated in malignant hypercalcaemia: cloning and expression // Science. — 1987. —
V.237. — P. 893 896.
Tabuenca A., Mohan S., Garberoglio C.A., Borgen P.I., Rosol T., Linkhart T.A.
Parathyroid hormone related protein: primary osteolytic factor produced by breast tumor
cells in vitro? // World J. Surg. — 1995. — V. 19(2). — P. 292 298.
Tahtela R., Tholix E.
Serum concentrations of type I collagen carboxyterminal
telopeptide (ICTP) and type I procollagen carboxy and aminoterminal propeptides
(PICP, PINP) as markers of metastatic bone disease in breast cancer // Anticancer Res. —
1996. — V. 16(4B). — P. 2289 2293.
Targuini B., Cheri R., Romano S.
Circadian variaton of serum prolactin and TSN of
women in helth or with mammary carcinoma, fibroadenoma or fybrocyctic mastopathy //
Int. J. of Chronobiol. — 1980. — V. 7(2). — P. 101 115.
249
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
